Brain imaging in children with neonatal cholestatic liver disease: A systematic review

Thora Wesenberg Helt1, Lars Søndergaard Johansen2, Daniel Faurholt-Jepsen3,4

  • 1Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Denmark.

Insights

Neonatal cholestasis in children can cause brain imaging abnormalities, potentially impacting neuropsychological development. Further research is needed to understand the exact causes of these impairments.

Area of Science:

  • Pediatric Neurology
  • Hepatology
  • Medical Imaging

Background:

  • Neonatal cholestatic liver disease is a serious condition in infants.
  • Impaired neuropsychological development is a concern in affected children.
  • Brain imaging plays a crucial role in assessing neurological impact.

Approach:

  • A comprehensive literature search was conducted using Ovid MEDLINE and EMBASE.
  • Studies included children under 18 with neonatal cholestasis and brain scans.
  • Data on demographics, imaging findings, treatment, and outcomes were extracted and summarized.

Key Points:

  • Hemorrhage was the most frequent brain imaging finding in children with neonatal cholestasis.
  • Bile duct obstruction, particularly biliary atresia, was associated with a higher incidence of hemorrhage.
  • Some brain imaging abnormalities resolved following liver transplantation.

Conclusions:

  • Neonatal cholestasis is associated with brain imaging changes in children.
  • These changes may contribute to impaired neuropsychological development.
  • Longitudinal studies with structured assessments are required to clarify the etiology.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...